Ginkgo Bioworks Holdings Inc (DNA)
0.7677
-0.15
(-16.55%)
USD |
NYSE |
May 10, 16:00
0.7598
-0.01
(-1.03%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Market Cap: 1.691B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.027B |
| May 08, 2024 | 1.968B |
| May 07, 2024 | 2.057B |
| May 06, 2024 | 2.177B |
| May 03, 2024 | 2.104B |
| May 02, 2024 | 1.897B |
| May 01, 2024 | 1.855B |
| April 30, 2024 | 1.963B |
| April 29, 2024 | 2.180B |
| April 26, 2024 | 1.895B |
| April 25, 2024 | 1.713B |
| April 24, 2024 | 1.863B |
| April 23, 2024 | 1.918B |
| April 22, 2024 | 1.857B |
| April 19, 2024 | 1.905B |
| April 18, 2024 | 2.037B |
| April 17, 2024 | 1.920B |
| April 16, 2024 | 2.012B |
| April 15, 2024 | 2.092B |
| April 12, 2024 | 2.224B |
| April 11, 2024 | 2.312B |
| April 10, 2024 | 2.466B |
| April 09, 2024 | 2.497B |
| April 08, 2024 | 2.389B |
| April 05, 2024 | 2.325B |
| Date | Value |
|---|---|
| April 04, 2024 | 2.303B |
| April 03, 2024 | 2.346B |
| April 02, 2024 | 2.260B |
| April 01, 2024 | 2.411B |
| March 28, 2024 | 2.497B |
| March 27, 2024 | 2.368B |
| March 26, 2024 | 2.303B |
| March 25, 2024 | 2.346B |
| March 22, 2024 | 2.303B |
| March 21, 2024 | 2.454B |
| March 20, 2024 | 2.475B |
| March 19, 2024 | 2.346B |
| March 18, 2024 | 2.346B |
| March 15, 2024 | 2.325B |
| March 14, 2024 | 2.282B |
| March 13, 2024 | 2.518B |
| March 12, 2024 | 2.518B |
| March 11, 2024 | 2.626B |
| March 08, 2024 | 2.626B |
| March 07, 2024 | 2.583B |
| March 06, 2024 | 2.626B |
| March 05, 2024 | 2.475B |
| March 04, 2024 | 2.712B |
| March 01, 2024 | 2.777B |
| February 29, 2024 | 3.272B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.691B
Minimum
May 10 2024
24.96B
Maximum
Nov 08 2021
5.837B
Average
4.046B
Median
Market Cap Benchmarks
| Agenus Inc | 218.68M |
| Teladoc Health Inc | 2.026B |
| Sarepta Therapeutics Inc | 12.47B |
| Ultragenyx Pharmaceutical Inc | 3.399B |
| Apellis Pharmaceuticals Inc | 5.095B |
Market Cap Related Metrics
| PS Ratio | 5.937 |
| Price to Book Value | 1.541 |
| Price | 0.7677 |
| Earnings Yield | -61.22% |